5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.34▼ | 1.34▼ | 1.33▼ | 1.33▼ | 1.64▼ |
MA10 | 1.34▼ | 1.33▼ | 1.34▼ | 1.52▼ | 1.86▼ |
MA20 | 1.34▼ | 1.34▼ | 1.35▼ | 1.69▼ | 1.95▼ |
MA50 | 1.34▼ | 1.34▼ | 1.40▼ | 1.93▼ | 1.86▼ |
MA100 | 1.34▼ | 1.43▼ | 1.59▼ | 1.99▼ | 2.06▼ |
MA200 | 1.35▼ | 1.62▼ | 1.82▼ | 1.86▼ | 3.13▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.000▲ | 0.005▲ | -0.040▼ | -0.085▼ |
RSI | 38.567▼ | 46.334▼ | 44.155▼ | 28.235▼ | 34.757▼ |
STOCH | 50.000 | 55.556 | 30.202 | 19.680▼ | 24.544 |
WILL %R | -100.000▼ | -80.000▼ | -80.000▼ | -80.282▼ | -87.387▼ |
CCI | -223.188▼ | -22.447 | -36.782 | -75.669 | -220.189▼ |
▼ RSI | $HRTX RSI(14) Crossed Below 30 | Set Alert |
Friday, August 15, 2025 05:08 AM
Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that its Board of Directors (the "Board") has adopted a Section 382 rights ...
|
Tuesday, August 12, 2025 05:43 AM
Q2 2025 Earnings Call Transcript August 8, 2025 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $-0.01. Operator: Thank you for standing by, and ...
|
Saturday, August 09, 2025 12:17 AM
Heron Therapeutics Inc (HRTX) reports robust financial performance with $37.2 million in quarterly revenues, despite facing inventory and expense challenges.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.37 | 1.3787 | 1.32 | 1.33 | 1,780,286 |
14/08/25 | 1.40 | 1.41 | 1.3146 | 1.35 | 1,525,270 |
13/08/25 | 1.47 | 1.47 | 1.315 | 1.40 | 4,110,509 |
12/08/25 | 1.29 | 1.3289 | 1.25 | 1.31 | 2,710,562 |
11/08/25 | 1.39 | 1.39 | 1.19 | 1.28 | 4,846,539 |
08/08/25 | 1.44 | 1.46 | 1.23 | 1.32 | 14,961,575 |
07/08/25 | 1.79 | 1.86 | 1.7499 | 1.84 | 1,146,142 |
06/08/25 | 1.80 | 1.875 | 1.7835 | 1.81 | 682,335 |
05/08/25 | 1.75 | 1.83 | 1.725 | 1.81 | 894,071 |
04/08/25 | 1.70 | 1.76 | 1.68 | 1.75 | 1,208,529 |
|
|
||||
|
|
||||
|
|